CoChat
Sign Up
Cited by 591SARS-CoV-2 detection and testingCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

Open access
Dinnes, Jacqueline, Deeks, Jonathan J, Berhane, Sarah, Taylor, Melissa, Adriano, Ada, Davenport, Clare, Dittrich, Sabine, Emperador, Devy +15 more·2021·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd013705.pub2PMC PMC8078597
Open this paper in CoChat — free accountOpen PDF

Abstract

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd013705.pub2

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 263

  1. Albert E, Torres I, Bueno F, Huntley D, Molla E, Fernández-Fuentes MÁ, et al. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centers. Clinical Microbiology and Infection 2020 Nov 13 [Epub ahead of print]. [DOI: 10.1016/j.cmi.2020.11.004] PMC7662075 33189872 · DOI
  2. Albert E, Torres I, Bueno F, Huntley D, Molla E, Fernández-Fuentes MÁ, et al. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for the diagnosis of COVID-19 in primary healthcare centers. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.16.20213850] PMC7662075 33189872 · DOI
  3. Alemany A, Baro B, Ouchi D, Ubals M, Corbacho-Monné M, Vergara-Alert J, et al. Analytical and clinical performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test. medRxiv [Preprint] 2020. [DOI: 2020.10.30.20223198] PMC7788317 33421447
  4. Assennato SM, Ritchie AV, Nadala C, Goel N, Tie C, Nadala LM, et al. Performance evaluation of the SAMBA II SARS-CoV-2 test for point-of-care detection of SARS-CoV-2. Journal of Clinical Microbiology 2020; 59: e01262- 20. [DOI: doi.org/10.1128/JCM.01262-20] PMC7771448 33051242 · DOI
  5. Assennato SM, Ritchie AV, Nadala C, Goel N, Zhang H, Datir R, et al. Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 test for detection of SARS-CoV-2. medRxiv [Preprint] 24 May 2020. [DOI: 10.1101/2020.05.24.20100990] PMC7771448 33051242 · DOI
  6. Blairon L, Wilmet A, Beukinga I, Tre-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: experiences of a general hospital. Journal of Clinical Virology 2020; 129: 104472. [DOI: 10.1016/j.jcv.2020.104472] PMC7261076 32504944 · DOI
  7. Broder K, Babiker A, Myers C, White T, Jones H, Cardella J, et al. Test agreement between Roche cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges. Journal of Clinical Microbiology 2020; 58: e01187- 20. [DOI: 10.1128/JCM.01187-20] PMC7383541 32444354 · DOI
  8. Broder KJ, Babiker A, Myers C, White T, Jones H, Cardella J, et al. Test agreement between Roche cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges. bioRxiv [Preprint] 5 May 2020: 1- 13. [DOI: 10.1101/2020.05.05.078501] PMC7383541 32444354 · DOI
  9. Cerutti F, Burdino E, Milia MG, Allice T, Gregori G, Bruzzone B, et al. Urgent need of rapid tests for SARS CoV-2 antigen detection: evaluation of the SD-Biosensor antigen test for SARS-CoV-2. Journal of Clinical Virology 2020; 132: 104654. PMC7522649 33053494
  10. Chen JH, Yip CC, Poon RW, Chan KH, Cheng VC, Hung IF, et al. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerging Microbes and Infections 2020; 9(1): 1356- 9. PMC7448919 32459137
  11. Collier DA, Assennato SM, Sithole N, Sharrocks K, Ritchie A, Ravji P, et al. Rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical trial and implementation study. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.05.31.20114520] PMC7362826 32838340 · DOI
  12. Courtellemont L, Guinard J, Guillaume C, Giaché S, Rzepecki V, Seve A, et al. Real-life performance of a novel antigen detection test on nasopharyngeal specimens for SARS-CoV-2 infection diagnosis: a prospective study. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.28.20220657] PMC8014580 33615487 · DOI
  13. Cradic K, Lockhart M, Ozbolt P, Fatica L, Landon L, Lieber M, et al. Clinical evaluation and utilization of multiple molecular in vitro diagnostic assays for the detection of SARS-CoV-2. American Journal of Clinical Pathology 2020; 154(2): 201- 7. PMC7314271 32462195
  14. Cradic K, Lockhart M, Ozbolt P, Fatica L, Landon L, Lieber M, et al. Clinical evaluation and utilization of multiple molecular in vitro diagnostic assays for the detection of SARS-CoV-2. American Journal of Clinical Pathology 2020; 154(2): 201- 7. PMC7314271 32462195
  15. Diao B, Wen K, Chen J, Liu Y, Yuan Z, Han C, et al. Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. medRxiv [Preprint] 10 March 2020: 1- 13. [DOI: 10.1101/2020.03.07.20032524] · DOI
  16. Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y, et al. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect 2020 Oct 5 [Epub ahead of print]. [DOI: 10.1016/j.cmi.2020.09.057] PMC7534827 33031947 · DOI
  17. Dust K, Hedley A, Nichol K, Stein D, Adam H, Karlowsky JA, et al. Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2. Journal of Virological Methods 2020; 285: 113970. [DOI: 10.1016/j.jviromet.2020.113970] PMC7482591 32920028 · DOI
  18. Fenollar F, Bouam A, Ballouche M, Fuster L, Prudent E, Colson P, et al. Evaluation of the Panbio Covid-19 rapid antigen detection test device for the screening of patients with COVID-19. Journal of Clinical Microbiology 2020. [DOI: 10.1128/JCM.02589-20] PMC8111145 33139420 · DOI
  19. Fenollar F, Bouam A, Ballouche M, Fuster L, Prudent E, Colson P, et al. Evaluation of the Panbio Covid-19 rapid antigen detection test device for the screening of patients with COVID-19. Journal of Clinical Microbiology 2020. [DOI: 10.1128/JCM.02589-20] PMC8111145 33139420 · DOI
  20. Ghofrani M, Casas MT, Pelz RK, Kroll C, Blum N, Foster SD. Performance characteristics of the ID NOW COVID-19 assay: a regional health care system experience. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.03.20116327] · DOI
  21. Gibani MM, Toumazou C, Sohbati M, Sahoo R, Karvela M, Hon TK, et al. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study. Lancet Microbe 2020; 1(7): E300- E307. [DOI: 0.1016/S2666-5247(20)30121-X] PMC7498257 32964211
  22. Goldenberger D, Leuzinger K, Sogaard KK, Gosert R, Roloff T, Naegele K, et al. Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay. Journal of Virologica. Methods 2020; 284: 113925. PMC7351036 32659240
  23. Gremmels H, Winkel BM, Schuurman R, Rosingh A, Rigter NA, Rodriguez O, et al. Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.16.20214189] PMC7832943 33521610 · DOI
  24. Gremmels H, Winkel BM, Schuurman R, Rosingh A, Rigter NA, Rodriguez O, et al. Real-life validation of the PanbioTM COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. EClinicalMedicine 2021; 31: 100677. [DOI: doi.org/10.1016/j.eclinm.2020.100677] PMC7832943 33521610 · DOI
  25. Gremmels H, Winkel BM, Schuurman R, Rosingh A, Rigter NA, Rodriguez O, et al. Real-life validation of the PanbioTM COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.16.20214189] PMC7832943 33521610 · DOI
  26. Gupta A, Khurana S, Das R, Srigyan D, Singh A, Mittal A, et al. Rapid chromatographic immunoassay-based evaluation of COVID-19: a cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India. Indian Journal of Medical Research 2020 Oct 31 [Epub ahead of print]. [DOI: 10.4103/ijmr.IJMR_3305_20] PMC8184078 33818469 · DOI
  27. Harrington A, Cox B, Snowdon J, Bakst J, Ley E, Grajales P, et al. Comparison of Abbott ID NOW and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients. Journal of Clinical Microbiology 2020; 58(8): e00798- 20. [DOI: 10.1128/JCM.00798-20.] PMC7383519 32327448 · DOI
  28. Hogan CA, Garamani N, Lee AS, Tung JK, Sahoo MK, Huang C, et al. Comparison of the Accula SARS-CoV-2 test with a laboratory-developed assay for detection of SARS-CoV-2 RNA in clinical nasopharyngeal specimens. bioRxiv [Preprint] 2020. [DOI: 10.1101/2020.05.12.092379v1] PMC7383558 32461285 · DOI
  29. Hou H, Chen J, Wang Y, Lu Y, Zhu Y, Zhang B, et al. Multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the detection of SARS-CoV-2 in oropharyngeal swab specimens. Journal of Clinical Microbiology 2020. [DOI: doi.org/10.1128/JCM.01288-20] PMC7383560 32503847 · DOI
  30. Jin R, Pettengill MA, Hartnett NL, Auerbach HE, Peiper SC, Wang Z. Commercial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular assays: superior analytical sensitivity of cobas SARS-CoV-2 relative to NxTAG Cov Extended Panel and ID NOW COVID-19 test. Archives of Pathology and Laboratory Medicine 2020; 144(11): 1303- 10. 32649229
  31. Jokela P, Jääskeläinen AE, Jarva H, Holma T, Ahava M, Mannonen L, et al. SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.03.20145383] PMC7451096 32889495 · DOI
  32. Jokela P, Jääskeläinen AE, Jarva H, Holma T, Ahava MJ, Mannonen L, et al. SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility. Journal of Clinical Virology 2020; 131: 104614. PMC7451096 32889495
  33. Krüger LJ, Gaeddert M, Köppel L, Brümmer LE, Gottschalk C, Miranda IB, et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.01.20203836] · DOI
  34. Krüger LJ, Gaeddert M, Köppel L, Brümmer LE, Gottschalk C, Miranda IB, et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.01.20203836] · DOI
  35. Krüger LJ, Gaeddert M, Köppel L, Brümmer LE, Gottschalk C, Miranda IB, et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.10.01.20203836] · DOI
  36. Lambert-Niclot S, Cuffel A, Le Pape S, Vauloup-Fellous C, Morand-Joubert L, Roque-Afonso AM, et al. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab. Journal of Clinical Microbiology 2020; 58(8): e00977- 20. [DOI: 10.1128/JCM.00977-20] PMC7383555 32404480 · DOI
  37. Lephart PR, Bachman M, LeBar W, McClellan S, Barron K, Schroeder L, et al. Comparative study of four SARS-CoV-2 nucleic acid amplification test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type. bioRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.04.135616] PMC7470790 32980807 · DOI
  38. Lephart PR, Bachman M, LeBar W, McClellan S, Barron K, Schroeder L, et al. Comparative study of four SARS-CoV-2 nucleic acid amplification test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type. bioRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.04.135616] PMC7470790 32980807 · DOI
  39. Lieberman JA, Pepper G, Naccache SN, Huang ML, Jerome KR, Greninger AL. Comparison of commercially available and laboratory developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. Journal of Clinical Microbiology 2020; 58(8): e00821- 20. [DOI: 10.1128/JCM.00821-20] PMC7383518 32350048 · DOI
  40. Linares M, Pérez TR, Romanyk J, Pérez García F, Gómez-Herruz P, Arroyo T, et al. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.09.20.20198192] PMC7561603 33160179 · DOI
  41. Linares M, Pérez-Tanoira R, Carrero A, Romanyk J, Pérez-García F, Gómez-Herruz P, et al. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. Journal of Clinical Virology 2020; 133: 104659. PMC7561603 33160179
  42. Liotti FM, Menchinelli G, Lalle E, Palucci I, Marchetti S, Colavita F, et al. Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples. Clinical Microbiology and Infection 2020 Sep 23 [Epub ahead of print]. [DOI: 10.1016/j.cmi.2020.09.030] PMC7510559 32979567 · DOI
  43. Loeffelholz MJ, Alland D, Butler-Wu SM, Pandey U, Perno CF, Nava A, et al. Multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test. Journal of Clinical Microbiology 2020; 58(8): e00926- 20. [DOI: 10.1128/JCM.00926-20] PMC7383535 32366669 · DOI
  44. Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. Journal of Clinical Virology 2020; 129: 104500. PMC7278630 32585619
  45. Mertens P, De Vos N, Martiny D, Jassoy C, Mirazimi A, Cuypers L, et al. Development and potential usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a pandemic context. Frontiers in Medicine (Lausanne) 2020; 7: 225. PMC7227790 32574326
  46. Mertens P, De Vos N, Martiny D, Jassoy C, Mirazimi A, Cuypers L, et al. Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context. medRxiv [Preprint] 24 April 2020: 1- 29. [DOI: 10.1101/2020.04.24.20077776] PMC7227790 32574326 · DOI
  47. Mitchell SL, George KS. Evaluation of the COVID19 ID NOW EUA assay. Journal of Clinical Virology 2020; 128: 104429. [DOI: 10.1016/j.jcv.2020.104429] PMC7227587 32425657 · DOI
  48. Moore NM, Li H, Schejbal D, Lindsley J, Hayden M. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCOV RT-PCR assay for the qualitative detection of SARS-CoV-2 from upper respiratory tract specimens. medRxiv [Preprint] 2020: 1- 22. [DOI: 10.1101/2020.05.02.20088740] PMC7383545 32461287 · DOI
  49. Moore NM, Li H, Schejbal D, Lindsley J, Hayden MK. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2. Journal of Clinical Microbiology 2020; 58: e00938- 20. [DOI: doi.org/10.1128/JCM.00938-20] PMC7383545 32461287 · DOI
  50. Moran A, Beavis KG, Matushek SM, Ciaglia C, Francois N, Tesic V, et al. The detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 assays. Journal of Clinical Microbiology 2020; 58(8): e00772- 20. [DOI: 10.1128/JCM.00772-20] PMC7383516 32303565 · DOI
  51. Nagura-Ikeda M, Imai K, Tabata S, Miyoshi K, Murahara N, Mizuno T, et al. Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. Journal of Clinical Microbiology 2020; 58(9): e01438- 20. [DOI: 10.1128/JCM.01438-20] PMC7448663 32636214 · DOI
  52. Nash B, Badea A, Reddy A, Bosch M, Salcedo N, Gomez AR, et al. The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study. medRxiv [Preprint] 2020. [DOI: 2020.09.01.20184713]
  53. Peto T. COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing. medRxiv [Preprint] 2021. [DOI: doi.org/10.1101/2021.01.13.21249563] PMC8164528 34101770 · DOI
  54. Public Health England (PHE). Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. Public Health England, 2020.
  55. Public Health England (PHE). Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. Public Health England, 2020.
  56. Public Health England (PHE). Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. Public Health England, 2020.
  57. Public Health England (PHE). Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. Public Health England, 2020.
  58. Public Health England (PHE). Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. Public Health England, 2020.
  59. Public Health England (PHE). Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. Public Health England, 2020.
  60. Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, et al. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. International Journal of Infectious Diseases 2020; 99: 328- 33. PMC7263236 32497809
  61. Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, et al. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. papers.ssrn.com/abstract=3569871 [Preprint] 14 April 2020;(dx.doi.org/10.2139/ssrn.3569871): 1- 23. [DOI: dx.doi.org/10.2139/ssrn.3569871] PMC7263236 32497809 · DOI
  62. Porte L, Legarraga P, Iruretagoyena M, Vollrath V, Pizarro G, Munita JM, et al. Rapid SARS-CoV-2 antigen detection by immunofluorescence – a new tool to detect infectivity. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.10.04.20206466] · DOI
  63. Porte L, Legarraga P, Iruretagoyena M, Vollrath V, Pizarro G, Munita JM, et al. Rapid SARS-CoV-2 antigen detection by immunofluorescence – a new tool to detect infectivity. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.10.04.20206466] · DOI
  64. Rhoads DD, Cherian SS, Roman K, Stempak LM, Schmotzer CL, Sadri N. Comparison of Abbott ID NOW, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. Journal of Clinical Microbiology 2020; 58(8): e00760- 20. [DOI: 10.1128/JCM.00760-20] PMC7383529 32303564 · DOI
  65. Schildgen V, Demuth S, Lüsebrink J, Schildgen O. Limits and opportunities of SARS-CoV-2 antigen rapid tests – an experience based perspective. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.09.22.20199372] PMC7824818 33466537 · DOI
  66. Schildgen V, Demuth S, Lüsebrink J, Schildgen O. Limits and opportunities of SARS-CoV-2 antigen rapid tests – an experience based perspective. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.09.22.20199372] PMC7824818 33466537 · DOI
  67. Schildgen V, Demuth S, Lüsebrink J, Schildgen O. Limits and opportunities of SARS-CoV-2 antigen rapid tests – an experience based perspective. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.09.22.20199372] PMC7824818 33466537 · DOI
  68. Scohy A, Anantharajah A, Bodeus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. Journal of Clinical Virology 2020; 129: 104455. [DOI: 10.1016/j.jcv.2020.104455] PMC7240272 32485618 · DOI
  69. Shrestha B, Neupane AK, Pant S, Shrestha A, Bastola, A. Sensitivity and specificity of lateral flow antigen test kits for COVID-19 in asymptomatic population of quarantine centre of Province 3. Kathmandu University Medical Journal 2020; 18(70): 36- 9. 33605236
  70. Smithgall MC, Scherberkova I, Whittier S, Green D. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the rapid detection of SARS-CoV-2. bioRxiv [Preprint] 25 April 2020: 1- 16. [DOI: 10.1101/2020.04.22.055327] PMC7217789 32434706 · DOI
  71. Smithgall MC, Scherberkova I, Whittier S, Green DA. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche Cobas for the rapid detection of SARS-CoV-2. Journal of Clinical Virology 2020; 128: 104428. [DOI: 10.1016/j.jcv.2020.104428] PMC7217789 32434706 · DOI
  72. Smithgall MC, Scherberkova I, Whittier S, Green DA. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche Cobas for the rapid detection of SARS-CoV-2. Journal of Clinical Virology 2020; 128: 104428. [DOI: 10.1016/j.jcv.2020.104428] PMC7217789 32434706 · DOI
  73. SoRelle JA, Mahimainathan L, McCormick-Baw C, Cavuoti D, Lee F, Thomas A, et al. Saliva for use with a point of care assay for the rapid diagnosis of COVID-19. Clinica Chimica Acta 2020; 510: 685- 6. PMC7476885 32910978
  74. SoRelle Jeffrey, Mahimmainathan Lenin, McCormick-Baw Clare, Cavuoti Dominick, Lee Franceca, Bararia Anjali, et al. Evaluation of symptomatic patient saliva as a sample type for the Abbott ID NOW COVID-19 assay. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.01.20119198] · DOI
  75. Stevens B, Hogan CA, Sahoo MK, Huang C, Garamani N, Zehnder J, et al. Comparison of a point-of-care assay and a high-complexity assay for detection of SARS-CoV-2 RNA. Journal of Applied Laboratory Medicine 2020; 5(6): 1307- 12. PMC7454585 32761092
  76. Szymczak WA, Goldstein DY, Orner EP, Fecher RA, Yokoda RT, Skalina KA, et al. Utility of stool PCR for the diagnosis of COVID-19: comparison of two commercial platforms. Journal of Clinical Microbiology 2020; 58: e01369- 20. [DOI: doi.org/10.1128/JCM.01369-20] PMC7448643 32611796 · DOI
  77. Takeda Y, Mori M, Omi K. SARS-CoV-2 qRT-PCR Ct value distribution in Japan and possible utility of rapid antigen testing kit. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.06.16.20131243] · DOI
  78. Thwe PM, Ren P. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory. Diagnostic Microbiology and Infectious Disease 2020; 98(2): 115123. [DOI: 10.1016/j.diagmicrobio.2020.115123] PMC7334653 32673978 · DOI
  79. Van der Moeren N, Zwart VF, Lodder EB, Van den Bijllaardt W, Van Esch HR, Stohr JJ, et al. Performance evaluation of a SARS-CoV-2 rapid antigen test: test performance in the community in the Netherlands. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.10.19.20215202] · DOI
  80. Van der Moeren N, Zwart VF, Lodder EB, Van den Bijllaardt W, Van Esch HR, Stohr JJ, et al. Performance evaluation of a SARS-CoV-2 rapid antigen test: test performance in the community in the Netherlands. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.10.19.20215202] · DOI
  81. Veyrenche N, Bollore K, Pisoni A, Bedin A-S, Mondain A-M, Ducos J, et al. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.09.19.20197855] PMC8013599 33554363 · DOI
  82. Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Araos R, et al. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples. bioRxiv [Preprint] 30 May 2020: 1- 21. [DOI: 10.1101/2020.05.27.119255] PMC7263236 32497809 · DOI
  83. Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Porte L, et al. Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. Travel Medicine and Infectious Diseases 2020 Dec 2 [Epub ahead of print]: 101942. [DOI: 10.1016/j.tmaid.2020.101942] PMC7708826 33278609 · DOI
  84. Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Araos R, et al. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples. bioRxiv [Preprint] 30 May 2020: 1- 21. [DOI: 10.1101/2020.05.27.119255] PMC7263236 32497809 · DOI
  85. Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Araos R, et al. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples. bioRxiv [Preprint] 30 May 2020: 1- 21. [DOI: 10.1101/2020.05.27.119255] PMC7263236 32497809 · DOI
  86. Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Araos R, et al. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples. bioRxiv [Preprint] 30 May 2020: 1- 21. [DOI: 10.1101/2020.05.27.119255] PMC7263236 32497809 · DOI
  87. Wolters F, Van de Bovenkamp J, Van den Bosch B, Van den Brink S, Broeders M, Chung NH, et al. Multi-center evaluation of Cepheid Xpert(R) Xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic. Journal of Clinical Virology 2020; 128: 104426. [DOI: 10.1016/j.jcv.2020.104426] PMC7211760 32417674 · DOI
  88. Wong RC, Wong AH, Ho YI, Leung EC, Lai RW. Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay. Journal of Clinical Virology 2020; 131: 104593. [DOI: 10.1016/j.jcv.2020.104593 ] PMC7429071 32823131 · DOI
  89. Young S, Taylor S, Cammarata C, Roger-Dalbert C, Montano A, Griego-Fullbright C, et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.09.01.20185777] PMC7771450 33023911 · DOI
  90. Young S, Taylor SN, Cammarata CL, Varnado KG, Roger-Dalbert C, Montano A, et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test. Journal of Clinical Microbiology 2020. [DOI: 10.1128/JCM.02338-20] PMC7771450 33023911 · DOI
  91. Zhen W, Smith E, Manji R, Schron D, Berry GJ. Clinical evaluation of three sample-to-answer platforms for the detection of SARS-CoV-2. Journal of Clinical Microbiology 2020; 58(8): e00783- 20. [DOI: 10.1128/JCM.00783-20] PMC7383520 32332061 · DOI
  92. Zhen W, Smith E, Manji R, Schron D, Berry GJ. Clinical evaluation of three sample-to-answer platforms for the detection of SARS-CoV-2. Journal of Clinical Microbiology 2020; 58(8): e00783- 20. [DOI: 10.1128/JCM.00783-20] PMC7383520 32332061 · DOI
  93. Ai JW, Zhang HC, Xu T, Wu J, Zhu M, Yu YQ, et al. Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China. medRxiv [Preprint] 17 February 2020: 1- 18. [DOI: 10.1101/2020.02.13.20022673] · DOI
  94. Anahtar MN, McGrath GE, Rabe BA, Tanner NA, White BA, Lennerz JK, et al. Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification. medRxiv [Preprint] 18 May 2020: 1- 22. [DOI: 10.1101/2020.05.12.20095638] PMC7798487 34853795 · DOI
  95. Ar Gouilh M, Cassier R, Maille E, Schanen C, Rocque L-M, Vabret Astrid. An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for Point-of-Care and diagnostic lab. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.09.25.20200956] · DOI
  96. Arizti-Sanz J, Freije CA, Stanton AC, Boehm CK, Petros BA, Siddiqui S, et al. Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2. bioRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.05.28.119131] PMC7680145 33219225 · DOI
  97. Arumugam A, Faron ML, Yu P, Markham C, Wong S. A rapid COVID-19 RT-PCR detection assay for low resource settings. bioRxiv [Preprint] 30 April 2020: 1- 13. [DOI: 10.1101/2020.04.29.069591] · DOI
  98. Avetyan D, Chavushyan A, Ghazaryan H, Melkonyan A, Stepanyan A, Zakharyan R, et al. SARS-CoV-2 detection by extraction-free qRT-PCR for massive and rapid COVID-19 diagnosis during a pandemic. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.09.10.20191189] PMC8175123 34091213 · DOI
  99. Azhar M, Phutela R, Kumar M, Ansari AH, Rauthan R, Gulati S, et al. Rapid, accurate, nucleobase detection using FnCas9. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.09.13.20193581] PMC8020606 33866136 · DOI
  100. Azzi L, Baj A, Alberio T, Lualdi M, Veronesi G, Carcano G, et al. Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study. Journal of Infection 2020; 81(3): e75- 8. PMC7306212 32579988
  101. Baek YH, Um J, Antigua KJ, Park JH, Kim Y, Oh S, et al. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2. Emerging Microbes & Infections 2020; 9(1): 998- 1007. PMC7301696 32306853
  102. Barra GB, Ticiane Henriques SR, Goes MP, Henriques JR, Nery LF. Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow. medRxiv [Preprint] 10 March 2020: 1- 5. [DOI: 10.1101/2020.03.07.20032326] PMC7599812 33053675 · DOI
  103. Basu A, Zinger T, Inglima K, Woo KM, Atie O, Yurasits L, et al. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution. Journal of Clinical Microbiology 2020; 58(8): e01136- 20. [DOI: 10.1128/JCM.01136-20] PMC7383552 32471894 · DOI
  104. Behrmann O, Bachmann I, Spiegel M, Schramm M, El Wahed AA, Dobler G, et al. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ). Clinical Chemistry 8 May 2020 [Epub ahead of print]: hvaa116. [DOI: 10.1093/clinchem/hvaa116] PMC7239256 32384153 · DOI
  105. Bokelmann L, Nickel O, Maricic T, Paabo S, Meyer M, Borte S, et al. Rapid, reliable, and cheap point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP (Cap-iLAMP). medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.08.04.20168617] PMC7935920 33674580 · DOI
  106. Bordi L, Piralla A, Lalle E, Giardina F, Colavita F, Tallarita M, et al. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa COVID-19 direct assay. Journal of Clinical Virology 2020; 128: 104416. PMC7198196 32388470
  107. Brandsma E, Verhagen HJ, Van de Laar TJ, Claas EC, Cornelissen M, Van den Akker E. Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.27.20147249] PMC7665660 33535237 · DOI
  108. Broughton JP, Deng X, Yu G, Fasching CL, Singh J, Streithorst J, et al. Rapid detection of 2019 novel coronavirus SARS-CoV-2 using a CRISPR-based DETECTR lateral flow assay. medRxiv [Preprint] 27 March 2020: 1- 28. [DOI: 10.1101/2020.03.06.20032334] · DOI
  109. Bull RA, Adikari TN, Ferguson JM, Hammond JM, Stevanovski I, Beukers AG, et al. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis. Nature Communications 2020; 11(1): 6272. PMC7726558 33298935
  110. Bulterys PL, Garamani N, Stevens B, Sahoo MK, Huang C, Hogan CA, et al. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2. Journal of Clinical Virology 2020; 129: 104427. PMC7207111 32535398
  111. Callahan CJ, Lee R, Zulauf K, Tamburello L, Smith KP, Previtera J, et al. Open development and clinical validation of multiple 3D-printed sample-collection swabs: rapid resolution of a critical COVID-19 testing bottleneck. medRxiv [Preprint] 7 May 2020: 1- 16. [EMBASE: 10.1101/2020.04.14.20065094] PMC7383530 32393482 · DOI
  112. Callahan CJ, Lee R, Zulauf KE, Tamburello L, Smith KP, Previtera J, et al. Open development and clinical validation of multiple 3D-printed nasopharyngeal collection swabs: rapid resolution of a critical COVID-19 testing bottleneck. Journal of Clinical Microbiology 2020; 58(8): e00876- 20. [DOI: 10.1128/JCM.00876-20] PMC7383530 32393482 · DOI
  113. Callahan C, Lee R, Lee G, Zulauf K E, Kirby J E, Arnaout R. Nasal-swab testing misses patients with low SARS-CoV-2 viral loads. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.12.20128736] · DOI
  114. Chandler-Brown D, Bueno AM, Atay O, Tsao DS. A highly scalable and rapidly deployable RNA extraction-free COVID-19 assay by quantitative Sanger sequencing. medRxiv [Preprint] 10 April 2020: 1- 15. [DOI: 10.1101/2020.04.07.029199] · DOI
  115. Chen Y, Shi Y, Chen Y, Yang Z, Wu H, Zhou Z, et al. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron 2020; 169: 112642. PMC7502227 32979593
  116. Chow FW, Chan TT, Tam AR, Zhao S, Yao W, Fung J, et al. A rapid, simple, inexpensive, and mobile colorimetric assay COVID-19-LAMP for mass on-site screening of COVID-19. International Journal of Molecular Sciences 2020; 21(15): 5380. PMC7432162 32751106
  117. Colson P, Lagier JC, Baudoin JP, Bou Khalil J, La Scola B, Raoult D. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(8): 1601- 3. PMC7138953 32270412
  118. Comar M, Brumat M, Concas MP, Argentini G, Bianco A, Bicego L, et al. COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research hospital using combined molecular and rapid immunoassays test. medRxiv [Preprint] 22 April 2020: 1- 12. [DOI: 10.1101/2020.04.19.20071563] · DOI
  119. Comer SW, Fisk D. An extended laboratory validation study and comparative performance evaluation of the Abbott ID NOW COVID-19 Assay in a Coastal California tertiary care medical center. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.14.20130518] · DOI
  120. Crone MA, Priestman M, Ciechonska M, Jensen K, Sharp DJ, Randell P, et al. A new role for biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2. medRxiv [Preprint] 12 May 2020: 1- 31. [DOI: 10.1101/2020.05.02.20088344] · DOI
  121. Curti L, Pereyra-Bonnet F, Gimenez CA. An ultrasensitive, rapid, and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12. bioRxiv [Preprint] 2 March 2020: 1- 10. [DOI: 10.1101/2020.02.29.971127] · DOI
  122. Davda JN, Frank K, Prakash S, Purohit G, Vijayashankar DP, Vedagiri D, et al. An inexpensive RT-PCR endpoint diagnostic assay for SARS-CoV-2 using nested PCR: direct assessment of detection efficiency of RT-qPCR tests and suitability for surveillance. bioRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.08.139477] · DOI
  123. Ding X, Yin K, Li Z, Liu C. All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) assay: a case for rapid, ultrasensitive and visual detection of novel coronavirus SARS-CoV-2 and HIV virus. bioRxiv [Preprint] 21 March 2020: 1- 19. [DOI: 10.1101/2020.03.19.998724] · DOI
  124. Ding X, Yin K, Li Z, Lalla RV, Ballesteros E, Sfeir MM, et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nature Communications 2020; 11(1): 4711. PMC7501862 32948757
  125. Dohla M, Boesecke C, Schulte B, Diegmann C, Sib E, Richter E, et al. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity. Public Health 2020; 182: 170- 2. PMC7165286 32334183
  126. Dong Y, Wu X, Li S, Lu R, Wan Z, Qin J, et al. Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.22.20159525] PMC7858603 33536475 · DOI
  127. El-Tholoth M, Bau HH, Song J. A single and two-stage, closed-tube, molecular test for the 2019 novel coronavirus (COVID-19) at home, clinic, and points of entry. chemRxiv [Preprint] 2020; 19: 19. [DOI: 10.26434/chemrxiv.11860137] · DOI
  128. Farfan MJ, Torres JP, Oryan M, Olivares M, Gallardo P, Salas C. Optimizing RT-PCR detection of SARS-CoV-2 for developing countries using pool testing. medRxiv [Preprint] 17 April 2020: 1- 10. [DOI: 10.1101/2020.04.15.20067199] 32853320 · DOI
  129. Fowler VL, Armson B, Gonzales JL, Wise EL, Howson EL, Vincent-Mistiaen Z, et al. A reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 within nasopharyngeal and oropharyngeal swabs at Hampshire Hospitals NHS Foundation Trust. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.30.20142935] · DOI
  130. Francis R, Le Bideau M, Jardot P, Grimaldier C, Raoult D, Khalil JY, et al. High speed large scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled with high content screening. bioRxiv [Preprint] 19 May 2020: 1- 23. [DOI: 10.1101/2020.05.14.097295] PMC7510445 32979576 · DOI
  131. Freire-Paspuel B, Vega-Marino P, Velez A, Cruz M, Bereguiain MA. High sensitivity CDC EUA SARS-CoV-2 kit-based End Point-PCR assay. medRxiv [Preprint] 18 May 2020: 1- 7. [DOI: 10.1101/2020.05.11.20098590] · DOI
  132. Freire-Paspuel B, Vega-Marino P, Velez A, Castillo P, Cruz M, Garcia-Bereguiain MA. Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies. Journal of Clinical Virology 2020; 128: 104454. [DOI: 10.1016/j.jcv.2020.104454] PMC7243755 32485473 · DOI
  133. Ganguli A, Mostafa A, Berger J, Aydin M, Sun F, Valera E, et al. Rapid isothermal amplification and portable detection system for SARS-CoV-2. bioRxiv [Preprint] 21 May 2020: 1- 31. [DOI: 10.1101/2020.05.21.108381] PMC7502724 32868442 · DOI
  134. Gonzalez-Gonzalez E, Lara-Mayorga IM, Rodriguez-Sanchez IP, Yee-de Leon F, Garcia-Rubio A, Garciamendez-Mijares CE, et al. Scaling diagnostics in times of COVID-19: rapid prototyping of 3D-printed water circulators for loop-mediated isothermal amplification (LAMP) and detection of SARS-CoV-2 virus. medRxiv [Preprint] 19 June 2020: 1- 39. [DOI: 10.1101/2020.04.09.20058651] · DOI
  135. Gonzalez-Gonzalez E, Trujillo-de Santiago G, Lara-Mayorga IM, Martinez-Chapa SO, Alvarez MM. Portable and accurate diagnostics for COVID-19: combined use of the miniPCR thermocycler and a well-plate reader for SARS-CoV-2 virus detection. PLoS One 2020; 15(8): e0237418. PMC7425953 32790779
  136. Grant PR, Turner MA, Shin GY, Nastouli E, Levett LJ. Extraction-free COVID-19 (SARS-CoV-2) diagnosis by RT-PCR to increase capacity for national testing programmes during a pandemic. bioRxiv [Preprint] 9 April 2020: 1- 6. [DOI: doi.org/10.1101/2020.04.06.028316] · DOI
  137. Hass KN, Bao M, He Q, Park M, Qin P, Du K. Integrated Micropillar Polydimethylsiloxane Accurate CRISPR Detection (IMPACT) system for rapid viral DNA sensing. bioRxiv [Preprint] 20 March 2020: 1- 10. [DOI: 10.1101/2020.03.17.994137] PMC7594154 33134706 · DOI
  138. Herrera V, Hsu V, Adewale A, Hendrix T, Johnson L, Kuhlman J, et al. Testing of healthcare workers exposed to COVID19 with rapid antigen detection. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.08.12.20172726] · DOI
  139. Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K, et al. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. International Journal of Infectious Diseases 2020; 99: 397- 402. PMC7422837 32800855
  140. Hogan CA, Sahoo MK, Huang C, Garamani N, Stevens B, Zehnder J, et al. Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2. Journal of Clinical Virology 2020; 127: 104383. PMC7195328 32353760
  141. Howson E, Kidd S, Sawyer J, Cassar C, Cross D, Lewis T, et al. Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP). medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.16.20155168] PMC7750029 33358911 · DOI
  142. Hu X, Deng Q, Li J, Chen J, Wang Z, Zhang X, et al. Development and clinical application of a rapid and sensitive loop-mediated isothermal amplification test for SARS-CoV-2 infection. medRxiv [Preprint] 29 May 2020: 1- 28. [DOI: 10.1101/2020.05.20.20108530] PMC7449630 32848011 · DOI
  143. Huang WE, Lim B, Hsu CC, Xiong D, Wu W, Yu Y, et al. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2. Microbial Biotechnology 2020; 13(4): 950- 61. PMC7264870 32333644
  144. Huang L, Ding L, Zhou J, Chen S, Chen F, Zhao C, et al. One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device. Biosensors & Bioelectronics 2021; 171: 112685. PMC7557276 33113383
  145. James P, Stoddart D, Harrington ED, Beaulaurier J, Ly L, Reid SW, et al. LamPORE: rapid, accurate and highly scalable molecular screening for SARS-CoV-2 infection, based on nanopore sequencing. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.08.07.20161737] · DOI
  146. Jiang M, Pan W, Arastehfar A, Fang W, ling L, Fang H, et al. Development and validation of a rapid single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high-throughput screening of COVID-19. medRxiv [Preprint] 27 March 2020: 1- 12. [DOI: 10.1101/2020.03.15.20036376] PMC7313420 32626666 · DOI
  147. Joung J, Ladha A, Saito M, Segel M, Bruneau R, Huang MW, et al. Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv [Preprint] 8 May 2020: 1- 21. [DOI: 10.1101/2020.05.04.20091231] · DOI · Paper page
  148. Joung J, Ladha A, Saito M, Kim NG, Woolley AE, Segel M, et al. Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing. New England Journal of Medicine 2020; 383(15): 1492- 4. PMC7510942 32937062
  149. Kalikiri MK, Hasan M, Mirza F, Xaba T, Tang P, Lorenz S. High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads. medRxiv [Preprint] 11 April 2020: 1- 5. [DOI: 10.1101/2020.04.08.20055731] · DOI
  150. Kashiwagi K, Ishii Y, Aoki K, Yagi S, Maeda T, Miyazaki T, et al. Immunochromatographic test for the detection of SARS-CoV-2 in saliva. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.05.20.20107631] PMC7755575 33397587 · DOI
  151. Kim JH, Kang M, Park E, Chung DR, Kim J, Hwang ES. A simple and multiplex Loop-Mediated isothermal Amplification (LAMP) assay for rapid detection of SARS-CoV. Biochip Journal 2019; 13(4): 341- 51. PMC7097549 32226589
  152. Kim Y, Yaseen AB, Kishi JY, Hong F, Saka SK, Sheng K, et al. Single-strand RPA for rapid and sensitive detection of SARS-CoV-2 RNA. medRxiv [Preprint] 2020. [DOI: 10.1101/2020.08.17.20177006] · DOI
  153. Konrad R, Eberle U, Dangel A, Treis B, Berger A, Bengs K, et al. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro Surveillance 2020; 25(9): 2000173. PMC7068163 32156330
  154. Kurstjens S, Van der Horst A, Herpers R, Geerits MW, Kluiters-de Hingh YC, Göttgens E-L, et al. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing. bioRxiv [Preprint] 4 April 2020: 1- 21. [DOI: 10.1101/2020.04.20.20067512] 32598302 · DOI
  155. Kyosei Y, Namba M, Yamura S, Takeuchi R, Aoki N, Nakaishi K, et al. Proposal of de novo antigen test for COVID-19: ultrasensitive detection of spike proteins of SARS-CoV-2. Diagnostics (Basel) 2020; 10(8): 594. PMC7459804 32823866
  156. Lalli MA, Chen X, Langmade SJ, Fronick CC, Sawyer CS, Burcea LC, et al. Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP. medRxiv [Preprint] 11 May 2020: 1- 25. [DOI: 10.1101/2020.05.07.20093542] · DOI
  157. Lamb LE, Bartolone SN, Ward E, Chancellor MB. Rapid detection of novel coronavirus (COVID-19) by reverse transcription-loop-mediated isothermal amplification. medRxiv [Preprint] 24 February 2020: 1- 17. [DOI: 10.1101/2020.02.19.20025155] PMC7292379 32530929 · DOI
  158. Landry ML, Criscuolo J, Peaper DR. Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients. Journal of Clinical Virology 2020; 130: 104567. PMC7392849 32750665
  159. Lee JY, Best N, McAuley J, Porter JL, Seemann T, Schultz MB, et al. Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA. Journal of Medical Microbiology 2020; 69(9): 1169- 78. PMC7656183 32755529
  160. Lee JY, Best N, McAuley J, Porter JL, Seemann T, Schultz MB, et al. Validation of a single-step, single-tube reverse transcription-loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA. bioRxiv [Preprint] 30 April 2020. [DOI: 10.1101/2020.04.28.067363] PMC7656183 32755529 · DOI
  161. Le Hingrat Q, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, et al. SARS-CoV-2 N-antigenemia: a new alternative to nucleic acid amplification techniques. medRxiv [Preprint] 2020.
  162. Li M, Zhao Y, Li Y, Chen X, Luo D, Luo M, et al. Development and evaluation of a novel RT-PCR system for reliable and rapid SARS-CoV-2 screening of blood donations. Transfusion 2020; 60(12): 2952- 61. PMC7461364 32798248
  163. Lin CY, Hwang D, Chiu NC, Weng LC, Liu HF, Mu JJ, et al. Increased detection of viruses in children with respiratory tract infection using PCR. International Journal of Environmental Research and Public Health 2020; 17(2): 564. PMC7013517 31952364
  164. Liotti FM, Menchinelli G, Marchetti S, Morandotti GA, Sanguinetti M, Posteraro B, et al. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection. Clinical Microbiology and Infection 2020; 26(12): 1699- 700. PMC7385983 32735938
  165. Lowe CF, Matic N, Ritchie G, Lawson T, Stefanovic A, Champagne S, et al. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays. Journal of Clinical Virology 2020; 128: 104387. PMC7187880 32380382
  166. Lu R, Wu X, Wan Z, Li Y, Zuo L, Qin J, et al. Development of a novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2. Virologica Sinica 2020; 35(3): 344- 7. PMC7110266 32239445
  167. Lu R, Wu X, Wan Z, Li Y, Jin X, Zhang C. A novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2. International Journal of Molecular Sciences 2020; 21(8): 2826. PMC7216271 32325642
  168. Lubke N, Senff T, Scherger S, Hauka S, Andree M, Adams O, et al. Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials. Journal of Clinical Virology 2020; 130: 104579. PMC7405857 32795959
  169. Mahari S, Roberts A, Shahdeo D, Gandhi S. eCovSens-Ultrasensitive novel in-house built printed circuit board based electrochemical device for rapid detection of nCOVID-19 antigen, a spike protein domain 1 of SARS-CoV-2. bioRxiv [Preprint] 11 May 2020: 1- 20. [DOI: 10.1101/2020.04.24.059204] · DOI
  170. Marais G, Naidoo M, Hsiao NY, Valley-Omar Z, Smuts H, Hardie D. The implementation of a rapid sample preparation method for the detection of SARS-CoV-2 in a diagnostic laboratory in South Africa. PLoS One 2020; 15(10): e0241029. PMC7575110 33079951
  171. Marzinotto S, Mio C, Cifu A, Verardo R, Pipan C, Schneider C, et al. A streamlined approach to rapidly detect SARS-CoV-2 infection, avoiding RNA extraction. medRxiv [Preprint] 11 April 2020: 1- 10. [DOI: 10.1101/2020.04.06.20054114] PMC7727018 33343767 · DOI
  172. McCormick-Baw C, Morgan K, Gaffney D, Cazares Y, Jaworski K, Byrd A, et al. Saliva as an alternate specimen source for detection of SARS-CoV-2 in symptomatic patients using Cepheid Xpert Xpress SARS-CoV-2. Journal of Clinical Microbiology 2020; 58(8): e01109- 20. [DOI: 10.1128/JCM.01109-20] PMC7383538 32414838 · DOI
  173. McDonald S, Courtney DM, Clark AE, Muthukumar A, Lee F, Balani J, et al. Diagnostic performance of a rapid point-of-care test for SARS-CoV-2 in an urban emergency department setting. Academic Emergency Medicine 2020; 27(8): 764- 6. PMC7300492 32492760
  174. McRae MP, Simmons GW, Christodoulides NJ, Lu Z, Kang SK, Fenyo D, et al. Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19. medRxiv [Preprint] 22 April 2020. [DOI: 10.1101/2020.04.16.20068411] PMC7360344 32490853 · DOI
  175. Mei X, Lee HC, Diao K, Huang M, Lin B, Liu C, et al. Artificial intelligence-enabled rapid diagnosis of COVID-19 patients. medRxiv [Preprint] 7 May 2020. [DOI: 10.1101/2020.04.12.20062661] PMC7446729 32427924 · DOI
  176. Meyerson NR, Yang Q, Clark SK, Paige CL, Fattor WT, Gilchrist AR, et al. A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.16.20150250] · DOI
  177. Michel D, Danzer KM, Gross R, Conzelmann C, Muller JA, Freischmidt A, et al. Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA. Journal of Virological Methods 2020; 286: 113965. PMC7468345 32891677
  178. Mlcochova P, Collier D, Ritchie A, Assennato SM, Hosmillo M, Goel N, et al. Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant. Cell Reports. Medicine 2020; 1(6): 100099. PMC7462534 32905045
  179. Mohon AN, Oberding L, Hundt J, Van Marle G, Pabbaraju K, Berenger BM, et al. Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2. Journal of Virological Methods 2020; 286: 113972. PMC7490281 32941977
  180. Moses SE, Warren C, Robinson P, Curtis J, Asquith S, Holme J, et al. Endpoint PCR Detection of Sars-CoV-2 RNA. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.21.20158337] · DOI
  181. Mostafa HH, Hardick J, Morehead E, Miller JA, Gaydos CA, Manabe YC. Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. Journal of Clinical Virology 2020; 130: 104578. PMC7405824 32777761
  182. Muraoka M, Tanoi Y, Tada T, Mizukoshi M, Kawaguchi O. Quickly and simply detection for coronavirus including SARS-CoV-2 on the mobile real-time PCR device and without RNA Extraction. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.08.06.20168294] · DOI
  183. Nachtigall FM, Pereira A, Trofymchuk OS, Santos LS. Detection of SARS-CoV-2 in nasal swabs using MALDI-MS. Nature Biotechnology 2020; 38(10): 1168- 73. 32733106
  184. Newman CM, Dudley DM, Wiseman RW, McLaughlin MT, Karl JA, Stauss MR, et al. Initial evaluation of a mobile SARS-CoV-2 RT-LAMP testing strategy. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.07.28.20164038] PMC8730517 35035293 · DOI
  185. Noerz D, Fischer N, Schultze A, Kluge S, Mayer-Runge U, Aepfelbacher M, et al. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting. Journal of Clinical Virology 2020; 128: 104390. PMC7187839 32388471
  186. Ogawa T, Fukumori T, Nishihara Y, Sekine T, Okuda N, Nishimura T, et al. Another false-positive problem for a SARS-CoV-2 antigen test in Japan. Journal of Clinical Virology 2020; 131: 104612. PMC7445490 32871543
  187. Osterdahl MF, Lee KA, Ni LM, Wilson S, Douthwaite S, Horsfall R, et al. Detecting SARS-CoV-2 at point of care: preliminary data comparing Loop-mediated Isothermal Amplification (LAMP) to PCR. medRxiv [Preprint] 4 April 2020: 1- 9. [DOI: 10.1101/2020.04.01.20047357] PMC7574392 33081710 · DOI
  188. Paden CR, Tao Y, Queen K, Zhang J, Li Y, Uehara A, et al. Rapid, sensitive, full genome sequencing of severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2). bioRxiv [Preprint] 24 April 2020: 1- 13. [DOI: 10.1101/2020.04.22.055897] PMC7510745 32610037 · DOI
  189. Patchsung M, Jantarug K, Pattama A, Aphicho K, Suraritdechachai S, Meesawat P, et al. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nature Biomedical Engineering 2020; 4(12): 1140- 9. 32848209
  190. Pellanda LC, Wendland EM, McBride AJ, Tovo-Rodrigues L, Ferreira MR, Dellagostin OA, et al. Sensitivity and specificity of a rapid test for assessment of exposure to SARS-CoV-2 in a community-based setting in Brazil. medRxiv [Preprint] 10 May 2020: 1- 10. [DOI: 10.1101/2020.05.06.20093476] · DOI
  191. Peto L, Rodger G, Carter DP, Osman KL, Yavuz M, Johnson K, et al. Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.09.18.20195370] PMC8315953 33782112 · DOI
  192. Pfefferle S, Reucher S, Norz D, Lutgehetmann M. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. EuroSurveillance 2020; 25(9): 2000152. PMC7068162 32156329
  193. Pollock NR, Savage TJ, Wardell H, Lee R, Mathew A, M Stengelin, et al. Correlation of SARS-CoV-2 nucleocapsid antigen and RNA concentrations in nasopharyngeal samples from children and adults using an ultrasensitive and quantitative antigen assay. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.11.10.20227371] PMC8092747 33441395 · DOI
  194. Qian J, Boswell SA, Chidley C, Lu ZX, Pettit ME, Gaudio BL, et al. An enhanced isothermal amplification assay for viral detection. bioRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.05.28.118059] PMC7679446 33219228 · DOI
  195. Rabe BA, Cepko C. SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification. Proceedings of the National Academy of Sciences of the United States of America 2020; 117(39): 24450- 8. PMC7533677 32900935
  196. Rauch JN, Valois E, Ponce-Rojas JC, Aralis Z, Lach RS, Zappa F, et al. CRISPR-based and RT-qPCR surveillance of SARS-CoV-2 in asymptomatic individuals uncovers a shift in viral prevalence among a university population. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.08.06.20169771] · DOI
  197. Rodel J, Egerer R, Suleyman A, Sommer-Schmid B, Baier M, Henke A, et al. Use of the variplex SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. Journal of Clinical Virology 2020; 132: 104616. PMC7457909 32891938
  198. Rodriguez-Manzano J, Malpartida-Cardenas K, Moser N, Pennisi I, Cavuto M, Miglietta L, et al. A handheld point-of-care system for rapid detection of SARS-CoV-2 in under 20 minutes. medRxiv [Preprint] 2020. [DOI: doi.org/10.1101/2020.06.29.20142349] PMC7839415 33649735 · DOI
  199. Seo G, Lee G, Kim MJ, Baek SH, Choi M, Ku KB, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano 2020; 14(4): 5135- 42. 32293168
  200. Shirato K, Nao N, Matsuyama S, Takeda M, Kageyama T. An ultra-rapid real-time RT-PCR method using the PCR1100 to detect severe acute respiratory syndrome coronavirus-2. Japanese Journal of Infectious Diseases 2020 Jun 30 [Epub ahead of print]. [DOI: 10.7883/yoken.JJID.2020.324] 32611983 · DOI

200 of 263 shown

Cited by

Sorted by citations

Authors
Dinnes, J., Deeks, J. J., Berhane, S., Taylor, M., Adriano, A., Davenport, C., Dittrich, S., Emperador, D., Takwoingi, Y., Cunningham, J., Beese, S., Domen, J., Dretzke, J., Ferrante di Ruffano, L., Harris, I. M., Price, M. J., Taylor-Phillips, S., Hooft, L., Leeflang, M. M., McInnes, M. D., Spijker, R., Van den Bruel, A., & Cochrane COVID-19 Diagnostic Test Accuracy Group
Affiliations
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Liverpool School of Tropical Medicine (GB)
  • University of Birmingham (GB)
  • FIND (CH)
  • World Health Organization (CH)
  • KU Leuven (BE)
  • Reviews and Information Services; York Health Economics Consortium; York UK
  • Division of Health Sciences, Warwick Medical School; University of Warwick; Coventry UK
  • Utrecht University (NL)
  • Amsterdam University Medical Centers (NL)
  • University of Ottawa (CA)
  • Department of Public Health and Primary Care; KU Leuven; Leuven Belgium
Corresponding author
Deeks, Jonathan J
ORCID
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2021-03-24
Volume
2022
Issue
7
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
DOI
10.1002/14651858.cd013705.pub2
PMC
PMC8078597
OpenAlex
W4237690308
Cited by
591
References
6
Citations by year
2026: 7 · 2025: 36 · 2024: 46 · 2023: 116 · 2022: 246 · 2021: 139 · 2020: 1
FWCI
16.03
Type
journal article
Language
en
Update notices
new_version (2022-07-22)
Open access
Licence
cc-by-nc-sa
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion, cc-by-nc-sa)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • University of Birmingham Research Portal (University of Birmingham) (acceptedVersion, cc-by-nc-sa)
  • Lirias (KU Leuven) (submittedVersion, cc-by-nc-sa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • World Health Organization
  • Wellcome Trust (210688/Z/18/Z)
  • University Hospitals Birmingham NHS Foundation Trust
  • National Institute for Health and Care Research (PDF-2017-10-059, CDF-2016-09-018, COVID-19, CS-2015-15-016, NIHR-RM-SR-2017-09-021-001)
  • Department of Health and Social Care (COVID-19)
  • Birmingham Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
SARS-CoV-2, COVID-19 pandemic, point-of-care testing, antigen testing, rapid diagnostic tests, molecular tests, infection diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review